Quantcast
Home / News / Generic Reglan claim isn’t preempted

Generic Reglan claim isn’t preempted

Federal law does not preempt a product liability suit against drug maker PLIVA based on the company’s alleged failure to update its warning label for the generic form of Reglan, the 6th U.S. Circuit Court of Appeals has ruled in reversing a dismissal.
Scroll To Top